David Elkins is the executive vice president and chief financial officer of Bristol-Myers Squibb, overseeing financial planning, accounting, tax/treasury and investor relations.
Elkins has more than 25 years of finance, strategy, operations, supply chain and business development experience in the United States, Europe and emerging markets. He joins Celgene from Johnson & Johnson (J&J), where he was worldwide vice president and CFO for consumer products, medical devices and corporate functions.
Prior to his leadership role at J&J, Elkins was CFO for Round Rock Research, a technology investigation and patent licensing company. From 2008 to 2012, Elkins was executive vice president and CFO of Becton, Dickinson and Company, a public global medical technology company. From 1995 to 2008, he held roles of increasing responsibility at AstraZeneca, and he began his career in finance at The Boeing Company in 1991.
Elkins holds a B.S. from the University of Delaware, an M.S. from the University of Pennsylvania, and an M.B.A. from Drexel University.
